Cancer patients suffer from the toxicity of chemotherapy. Antidote, given as a remedy limiting
poison, is an effective way to counteract toxicity. However, few antidotes abrogate …

Glioblastoma (GBM) is a highly aggressive and lethal type of brain tumor with complex and
diverse molecular signaling pathways involved that are in its development and progression …

Nanoparticles have been explored in glioblastomas as they can traverse the blood–brain
barrier and target glioblastoma selectively. However, direct observation of nanoparticle …

Cancer nanomedicines approved so far minimize toxicity, but their efficacy is often limited by
physiological barriers posed by the tumour microenvironment. Here, we discuss how these …

Glioblastoma (GBM), a highly aggressive form of brain cancer, is considered one of the
deadliest cancers, and even with the most advanced medical treatments, most affected …

As primary intracranial tumors of the central nervous system (CNS), gliomas pose formidable
challenges in the field of oncology due to their aggressiveness, poor prognosis, high risk of …

Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

Even though substantial advances in understanding glioma pathogenesis have prompted a
more rational design of potential therapeutic strategies, glioblastoma multiforme remains an …

Cancer continues to pose a severe threat to global health, making pursuing effective
treatments more critical than ever. Traditional therapies, although pivotal in managing …

Cancer treatment has dramatically evolved as understanding of the underlying biological
process has increased. As new treatments are developed and modified we expect increased …